Matrine suppresses cell growth of human chronic myeloid leukemia cells via its inhibition of the interleukin-6/Janus activated kinase/signal transducer and activator of transcription 3 signaling cohort

References

• Chen F, Huang K. Effects of the Chinese medicine matrine on experimental C. parvum infection in BALB/c mice and MDBK cells. Parasitol Res 2012;111:1827–1832.
   PubMed Web of Science ®Google Scholar
• Wan XY, Luo M, Li XD, et al. Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. Chem Biol Interact 2009;181:15–19.
   PubMed Web of Science ®Google Scholar
• Fu S, Sun C, Tao X, et al. Anti-inflammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes. Nat Prod Res 2012;26:1746–1749.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xiu J, Zhang X, et al. Antiviral effect of matrine against human enterovirus 71. Molecules 2012;17:10370–10376.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu Y, Ji W, et al. Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol 2014;35:5111–5119.
   PubMed Web of Science ®Google Scholar
• Sun M, Cao H, Sun L, et al. Antitumor activities of kushen: literature review. Evid Based Complement Alternat Med 2012;2012: 373219.
   PubMed Web of Science ®Google Scholar
• Yu HB, Zhang HF, Li DY, et al. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res 2011;13:242–250.
   PubMed Web of Science ®Google Scholar
• Song S, Zhu S, Zhang Z, et al. A study on the inhibitory effect of matrine on gastric cancer SGC-7901 cells. Afr J Tradit Complement Altern Med 2013;10:435–438.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang Y, Zhuang Y, et al. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation, PLoS One 2012;7:e46853.
   PubMed Web of Science ®Google Scholar
• Yu H, Jove R The STATs of cancer--new molecular targets come of age. Nat Rev Cancer 2004;4:97–105.
   PubMed Web of Science ®Google Scholar
• Brierley MM, Fish EN. Stats: multifaceted regulators of transcription, J Interferon Cytokine Res 2005;25:733–744.
   PubMed Web of Science ®Google Scholar
• Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis. Oncogene 2000;19:2474–2488.
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415–1421.
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr. STATs and gene regulation. Science 1997;277: 1630–1635.
   PubMed Web of Science ®Google Scholar
• Burger R. Impact of interleukin-6 in hematological malignancies. Transfus Med Hemother 2013;40:336–343.
   PubMed Web of Science ®Google Scholar
• Reynaud D, Pietras E, Barry-Holson K, et al. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 2011;20:661–673.
   PubMed Web of Science ®Google Scholar
• Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000;19:2548–2556.
   PubMed Web of Science ®Google Scholar
• SYoon S, Woo SU, Kang JH, et al. NF-kappaB and STAT3 cooperatively induce IL6 in starved cancer cells. Oncogene 2012; 31:3467–3481.
   PubMed Web of Science ®Google Scholar
• Bar-Natan M, Nelson EA, Xiang M, et al. STAT signaling in the pathogenesis and treatment of myeloid malignancies. JAKSTAT 2012;1:55–64.
   PubMedGoogle Scholar
• Benekli M, Baumann H, Wetzler M. Targeting signal transducer and activator of transcription signaling pathway in leukemias, J Clin Oncol 2009;27:4422–4432.
   PubMed Web of Science ®Google Scholar
• Benekli M, Baer MR, Baumann H, et al. Signal transducer and activator of transcription proteins in leukemias. Blood 2003; 101:2940–2954.
   PubMed Web of Science ®Google Scholar
• Epling-Burnette PK, Liu JH, Catlett-Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression, J Clin Invest 2001; 107:351–362.
   PubMed Web of Science ®Google Scholar
• Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells, J Immunol 2003;171:3863–3871.
   PubMed Web of Science ®Google Scholar
• Ma LD, Zhou M, Wen SH, et al. Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells. Leuk Lymphoma 2010;51:1326–1336.
   PubMed Web of Science ®Google Scholar
• Wang Q, Du H, Geng G, et al. Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells. Mol Biol Rep 2014;41:3009–3020.
   PubMed Web of Science ®Google Scholar
• Liang L, Wang XY, Zhang XH, et al. Sophoridine exerts an anti-colorectal carcinoma effect through apoptosis induction in vitro and in vivo. Life Sci 2012;91:1295–1303.
   PubMed Web of Science ®Google Scholar
• Sun M, Han J, Duan J, et al. Novel antitumor activities of Kushen flavonoids in vitro and in vivo. Phytother Res 2007;21: 269–277.
   PubMed Web of Science ®Google Scholar
• Xu MJ, Dong JF. Synergistic action between jasmonic acid and nitric oxide in inducing matrine accumulation of Sophora flavescens suspension cells. J Integr Plant Biol 2008;50:92–101.
   PubMed Web of Science ®Google Scholar
• Hu MJ, Zeng H, Wu YL, et al. Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice. Chin J Dig Dis 2005;6:68–71.
   PubMedGoogle Scholar
• Yu Q, Chen B, Zhang X, et al. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines. Planta Med 2013;79:775–781.
   PubMed Web of Science ®Google Scholar
• Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000;19:2496–2504.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;264:95–98.
   PubMed Web of Science ®Google Scholar
• Schuringa JJ, Wierenga AT, Kruijer W, et al. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6. Blood 2000; 95:3765–3770.
   PubMed Web of Science ®Google Scholar
• Pestell RG. New roles of cyclin D1. Am J Pathol 2013; 183:3–9.
   PubMed Web of Science ®Google Scholar
• Obaya AJ, Mateyak MK, Sedivy JM. Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene 1999;18: 2934–2941.
   PubMed Web of Science ®Google Scholar
• Bretones G, Delgado MD, Leon J. Myc and cell cycle control. Biochim Biophys Acta 2014 Apr 1. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Tomita N. BCL2 and MYC dual-hit lymphoma/leukemia. J Clin Exp Hematop 2011;51:7–12.
   PubMedGoogle Scholar
• Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene 2000;19:6627–6631.
   PubMed Web of Science ®Google Scholar
• Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999;10:105–115.
   PubMed Web of Science ®Google Scholar
• Liu S, Ma Z, Cai H, et al. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells. Eur J Haematol 2010;84:137–144.
   PubMed Web of Science ®Google Scholar